From: Validation of a HLA-A2 tetramer flow cytometric method, IFNgamma real time RT-PCR, and IFNgamma ELISPOT for detection of immunologic response to gp100 and MelanA/MART-1 in melanoma patients
gp100209
gp100pool
MART-1
Flu
HIV
1
2
3
4
15
5
6
9
8
7
0
241
Mean
3.3
2.6
3.5
35.4
2.5
SD
2.8
1.3
1.5
83.2
2.1
Mean + 2 SD
8.9
5.2
6.5
201.8
6.7